An interventional study of Concurrent Exercise Training and Taurine in Obesity (BMI>30), sponsored by University of Sao Paulo. Active, not recruiting at 1 site in Brazil. Open to female participants aged 60 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-07-28.
Sponsored by University of Sao Paulo · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Obesity by University of Sao Paulo — 5 open to participants now, 11 under way, none of them phase 3. Obesity · University of Sao Paulo.
Among the 42 studies in Obesity by University of Sao Paulo, this one is the 16th largest by planned enrollment of the 35 interventional ones that give a count, is one of 4 that started in 2026, is one of 30 with no phase, reaches primary completion later than 7 of the 10 other live ones, and was the 40th registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →5 of the 42 studies in Obesity by University of Sao Paulo are open now, in 1 country. Recruiting first, the newest first:
University of Sao Paulo · Sites in Brazil
Ages 10–14
University of Sao Paulo · Sites in Brazil
Ages 18–70
University of Sao Paulo · Sites in Brazil
Ages 18–45 · Women only
University of Sao Paulo · Sites in Brazil
Ages 18–45 · Women only
University of Sao Paulo
Ages 60–75 · Women only · Healthy volunteers
By country, each count listing its studies:
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 60 Years to 75 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 44 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 40 across the 35 interventional studies, 40 across the 7 observational. Of the 20 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Sao Paulo is the lead sponsor of 1,036 studies on the registry; 96 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
3 of the studies in Obesity by University of Sao Paulo that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07730255University of Sao PauloExercise and Taurine Supplementation on Intramuscular Fat in Older Women With Obesity | 2026-12 |
| NCT07466069University of Sao PauloLifestyle Intervention for Obesity and Eating Disorder Prevention in Transgender Adolescents | 2026-12 |
| NCT07910747University of Sao PauloEffects of Taurine Supplementation and Morning or Evening High-intensity Exercise on Circadian Clock Genes and Inflammatory Parameters in Adult Women With Obesity | 2027-04 |
Add all 3 to your calendar (.ics) → With an account.
Among the 42 studies in Obesity by University of Sao Paulo, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized clinical trial aims to investigate the effects of multicomponent concurrent exercise training associated or not with taurine supplementation on intramuscular fat infiltration, physical performance, transcriptomic profile, and metabolomic profile in older women with obesity. Forty women aged 60 to 75 years with obesity will be randomized into four groups: control, exercise, taurine, and exercise plus taurine. The intervention will last 16 weeks. Outcomes include magnetic resonance imaging, body composition, muscle biopsy, blood biomarkers, functional capacity tests, transcriptomic analysis, and metabolomic analysis.
Aging and obesity are associated with important physiological, metabolic, and functional alterations, including increased intramuscular fat infiltration, also known as myosteatosis. Intramuscular fat infiltration is associated with reduced muscle quality, impaired physical performance, metabolic dysfunction, insulin resistance, and increased risk of morbidity and mortality in older adults.
Physical exercise is recognized as an important non-pharmacological strategy to improve muscle function and metabolic health. In addition, taurine supplementation has demonstrated anti-inflammatory and metabolic effects that may contribute to the reduction of intramuscular fat accumulation and improvement of skeletal muscle health.
However, the synergistic effects of concurrent exercise training associated with taurine supplementation on intramuscular fat infiltration and molecular mechanisms involved in older women with obesity are still unclear.
Therefore, this randomized clinical trial aims to investigate the effects of physical exercise associated or not with taurine supplementation on intramuscular fat infiltration, physical performance, body composition, transcriptomic profile, and metabolomic profile in older women with obesity.
Forty women aged 60 to 75 years with obesity (Body mass index - BMI between 30 and 40 kg/m²) will be randomized into four groups:
Assessments performed before and after the intervention will include magnetic resonance imaging for intramuscular fat evaluation, body composition by dual-energy X-ray absorptiometry (DXA), muscle biopsy, blood biomarkers, indirect calorimetry, functional capacity tests, muscle strength, transcriptomic analysis, and metabolomic analysis.
This study may contribute to the development of innovative non-pharmacological strategies for obesity, aging, and intramuscular fat infiltration management.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will not receive exercise training or taurine supplementation, only the placebo.
Other: Placebo
Participants will undergo supervised concurrent exercise training three times per week for 16 weeks and will receive placebo.
Behavioral: Concurrent Exercise Training · Other: Placebo
Participants will receive 3 grams per day taurine supplementation for 16 weeks.
Dietary Supplement: Taurine
Participants will undergo supervised multicomponent concurrent exercise training combined with 3 grams per day taurine supplementation for 16 weeks.
Behavioral: Concurrent Exercise Training · Dietary Supplement: Taurine
Participants will perform supervised concurrent exercise training three times per week for 16 weeks. Exercise sessions will include warm-up, resistance exercises, aerobic training, and stretching exercises, according to American College of Sports Medicine (ACSM) recommendations for older adults.
Participants will receive 3 grams per day taurine supplementation administered orally in capsules for 16 weeks.
Participants will receive placebo capsules identical in appearance to taurine capsules.
Change from Baseline in Intramuscular Fat Fraction Assessed by Magnetic Resonance Imaging (Dixon Technique)
Intramuscular fat fraction assessed by magnetic resonance imaging (MRI) using the Dixon technique, reported as percentage (%) of fat within the muscle tissue. Change is calculated from baseline to Week 16.
Time frame: Baseline and 16 weeks
Change from baseline in skeletal muscle transcriptomic profile
Skeletal muscle biopsy samples will be analyzed using RNA sequencing to characterize changes in the skeletal muscle transcriptomic profile following the intervention.
Time frame: Baseline and 16 weeks
Change from baseline in plasma metabolomic profile
Plasma samples will be analyzed using untargeted metabolomic analysis to evaluate changes in the plasma metabolomic profile after 16 weeks of intervention.
Time frame: 16 weeks
Change from baseline in plasma taurine concentration
Plasma taurine concentration will be measured before and after the 16-week intervention.
Time frame: Baseline and 16 weeks
Change from baseline in Timed Up and Go test time
Functional mobility will be assessed using the Timed Up and Go test.
Time frame: Baseline and 16 weeks
Change from baseline in handgrip strength
Handgrip strength will be assessed using a hand dynamometer.
Time frame: Baseline and 16 weeks
Change from baseline in chair stand test performance
Lower-body functional performance will be assessed using the Chair Stand Test.
Time frame: Baseline and 16 weeks
Change from baseline in forearm flexion test performance
Upper-body muscular endurance will be assessed using the Forearm Flexion Test.
Time frame: Baseline and 16 weeks
Change from baseline in isokinetic knee extensor peak torque
Peak torque of the knee extensor muscles will be measured using an isokinetic dynamometer.
Time frame: Baseline and 16 weeks
Change from baseline in fat-free mass
Fat-free mass will be assessed by dual-energy X-ray absorptiometry.
Time frame: Baseline and 16 weeks
Change from baseline in fat mass
Fat mass will be assessed by dual-energy X-ray absorptiometry.
Time frame: Baseline and 16 weeks
Change from baseline in fasting blood glucose concentration
Fasting blood glucose concentration will be measured using blood samples collected after an overnight fast.
Time frame: Baseline and 16 weeks
Change from baseline in fasting insulin concentration
Fasting insulin concentration will be measured using blood samples collected after an overnight fast.
Time frame: Baseline and 16 weeks
Change from baseline in total cholesterol concentration
Total cholesterol concentration will be measured using fasting blood samples.
Time frame: Baseline and 16 weeks
Change from baseline in high-density lipoprotein cholesterol concentration
High-density lipoprotein cholesterol concentration will be measured using fasting blood samples.
Time frame: Baseline and 16 weeks
Change from baseline in low-density lipoprotein cholesterol concentration
Low-density lipoprotein cholesterol concentration will be measured using fasting blood samples.
Time frame: Baseline and 16 weeks
Change from baseline in triglyceride concentration
Triglyceride concentration will be measured using fasting blood samples.
Time frame: Baseline and 16 weeks
Change from baseline in resting metabolic rate
Resting metabolic will be assessed by indirect calorimetry after an overnight fast.
Time frame: Baseline and 16 weeks
Plan to share: No
No publications or documents are linked to this record.
Started May 2026 (actual). Primary completion is estimated for Dec 2026, 7 months after the start.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 7 months is below that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Taurine